ScienceDaily is reporting that a new vaccine used in the treatment of a cancer found primarliy in the brain is showing promising results
after an initial trial at the University of California. "Of the 12 patients being treated, eight can currently be evaluated for overall survival, while four are still receiving treatment. Seven out of the eight patients have exceeded the historical median benchmark of 6.5 months survival from time of recurrence. The investigators will continue to follow the patients for overall survival. Based on these results, a larger, multi-center phase 2 study is planned for late 2007."